Vicore Pharma AB
Major Drugs - Göteborg, Göteborg, Sw
Vicore Pharma AB Employees
Vicore Pharma AB Details
Vicore Pharma is a clinical-stage pharmaceutical company dedicated to creating life-changing treatments for severe lung diseases and related indications. The company currently has four development programs: VP01, VP02, VP03 and VP04. VP01 aims to develop the substance C21 for the treatment of idiopathic pulmonary fibrosis (IPF) and COVID-19. VP02 is based on a new formulation and delivery route of thalidomide and focuses on the severe, persistent cough associated with IPF. VP03 includes the development of new AT2R agonists. VP04 develops a clinically validated, CBT-based, digital therapeutic for IPF patients.The company's shares (VICO) are listed on Nasdaq Stockholm's main market. For more information, see www.vicorepharma.com.
Vicore Pharma AB Technologies
Email Providers
Outlook
CMS
WordPress.org
Fonts
Google Font API
Other
Mobile Friendly
Analytics and Tracking
Google Analytics